Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization. (Q49067136)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

based on heuristic

inferred from title

Escherichia coli

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

B Ahmed

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

M Loos

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

D Vanrompay

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

language of work or name

0 references

publication date

28 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

31

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

3909-3916

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24877767%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

The Epidemiology of Infections Caused by Escherichia coli O157: H7, Other Enterohemorrhagic E. coli, and the Associated Hemolytic Uremic Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Cytoskeleton-modulating effectors of enteropathogenic and enterohemorrhagic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

New insights in mucosal vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Recent progress in mucosal vaccine development: potential and limitations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Development of vaccine delivery vehicles based on lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Mucosal vaccination and therapy with genetically modified lactic acid bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Mucosal priming of the murine immune system against enterohemorrhagic Escherichia coli O157:H7 using Lactococcus lactis expressing the type III secretion system protein EspB.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Improved cloning vectors and transformation procedure for Lactococcus lactis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Secretion of biologically active murine interleukin-10 by Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Rectal inoculation of sheep with E. coli O157:H7 results in persistent infection in the absence of a protective immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

The role of Th1/Th2 polarization in mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

The regulation of IL-10 production by immune cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

A Lactococcus lactis gene encodes a membrane protein with putative ATPase activity that is homologous to the essential Escherichia coli ftsH gene product

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Controlled intra- or extracellular production of staphylococcal nuclease and ovine omega interferon in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Survival of lactococci during passage through mouse digestive tract.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral immunization of mice with recombinant Lactococcus lactis expressing Cu,Zn superoxide dismutase of Brucella abortus triggers protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral vaccination of mice against tetanus with recombinant Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Induction of mucosal and systemic immune responses following oral immunization of mice with Lactococcus lactis expressing human papillomavirus type 16 L1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Structure and function of the gut mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

The role of Th1 and Th2 cells for mucosal IgA responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Reduced faecal shedding of Escherichia coli O157:H7 in cattle following systemic vaccination with γ-intimin C280 and EspB proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Immunization of sheep with a combination of intiminγ, EspA and EspB decreases Escherichia coli O157:H7 shedding.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Non-toxigenic Escherichia coli O157:H7 strain NCTC12900 causes attaching-effacing lesions and eae-dependent persistence in weaned sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.05.054

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49067136&oldid=1984665367"